210 related articles for article (PubMed ID: 24295629)
1. Clinical pharmacology of comorbid attention deficit hyperactivity disorder in Tourette syndrome.
Rizzo R; Gulisano M
Int Rev Neurobiol; 2013; 112():415-44. PubMed ID: 24295629
[TBL] [Abstract][Full Text] [Related]
2. Tourette Syndrome and comorbid ADHD: current pharmacological treatment options.
Rizzo R; Gulisano M; Calì PV; Curatolo P
Eur J Paediatr Neurol; 2013 Sep; 17(5):421-8. PubMed ID: 23473832
[TBL] [Abstract][Full Text] [Related]
3. The relationship between tourette syndrome, attention deficit hyperactivity disorder, and stimulant medication: a critical review.
Erenberg G
Semin Pediatr Neurol; 2005 Dec; 12(4):217-21. PubMed ID: 16780292
[TBL] [Abstract][Full Text] [Related]
4. Prenatal and perinatal morbidity in children with Tourette syndrome and attention-deficit hyperactivity disorder.
Pringsheim T; Sandor P; Lang A; Shah P; O'Connor P
J Dev Behav Pediatr; 2009 Apr; 30(2):115-21. PubMed ID: 19322105
[TBL] [Abstract][Full Text] [Related]
5. Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome.
Spencer TJ; Sallee FR; Gilbert DL; Dunn DW; McCracken JT; Coffey BJ; Budman CL; Ricardi RK; Leonard HL; Allen AJ; Milton DR; Feldman PD; Kelsey DK; Geller DA; Linder SL; Lewis DW; Winner PK; Kurlan RM; Mintz M
J Atten Disord; 2008 Jan; 11(4):470-81. PubMed ID: 17934184
[TBL] [Abstract][Full Text] [Related]
6. Attention deficit hyperactivity disorder, tics and Tourette's syndrome: the relationship and treatment implications. A commentary.
Robertson MM
Eur Child Adolesc Psychiatry; 2006 Feb; 15(1):1-11. PubMed ID: 16514504
[TBL] [Abstract][Full Text] [Related]
7. Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome.
Jaworowski S; Benarroch F; Gross-Tsur V
J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):365-70. PubMed ID: 16768644
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological treatment of tic disorders and Tourette Syndrome.
Roessner V; Schoenefeld K; Buse J; Bender S; Ehrlich S; Münchau A
Neuropharmacology; 2013 May; 68():143-9. PubMed ID: 22728760
[TBL] [Abstract][Full Text] [Related]
9. An introduction to the clinical phenomenology of Tourette syndrome.
Martino D; Madhusudan N; Zis P; Cavanna AE
Int Rev Neurobiol; 2013; 112():1-33. PubMed ID: 24295616
[TBL] [Abstract][Full Text] [Related]
10. [Tourette syndrome: an analysis of its comorbidity and specific treatment].
Castellanos FX; Acosta MT
Rev Neurol; 2004 Feb; 38 Suppl 1():S124-30. PubMed ID: 15011166
[TBL] [Abstract][Full Text] [Related]
11. Life events and Tourette syndrome.
Steinberg T; Shmuel-Baruch S; Horesh N; Apter A
Compr Psychiatry; 2013 Jul; 54(5):467-73. PubMed ID: 23219489
[TBL] [Abstract][Full Text] [Related]
12. Sustained attention and impulsivity in children with Tourette syndrome: comorbidity and confounds.
Sherman EM; Shepard L; Joschko M; Freeman RD
J Clin Exp Neuropsychol; 1998 Oct; 20(5):644-57. PubMed ID: 10079041
[TBL] [Abstract][Full Text] [Related]
13. Emerging drugs in Tourette syndrome.
Silay YS; Jankovic J
Expert Opin Emerg Drugs; 2005 May; 10(2):365-80. PubMed ID: 15934872
[TBL] [Abstract][Full Text] [Related]
14. Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette's syndrome.
Spencer T; Biederman J; Steingard R; Wilens T
J Am Acad Child Adolesc Psychiatry; 1993 Jan; 32(1):211-4. PubMed ID: 8428875
[TBL] [Abstract][Full Text] [Related]
15. Tourette's syndrome and attention-deficit hyperactivity disorder: evidence for a genetic relationship.
Knell ER; Comings DE
J Clin Psychiatry; 1993 Sep; 54(9):331-7. PubMed ID: 8407852
[TBL] [Abstract][Full Text] [Related]
16. Tourette Syndrome and learning disabilities.
Burd L; Freeman RD; Klug MG; Kerbeshian J
BMC Pediatr; 2005 Sep; 5():34. PubMed ID: 16137334
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacology of comorbid obsessive-compulsive disorder in Tourette syndrome.
Neri V; Cardona F
Int Rev Neurobiol; 2013; 112():391-414. PubMed ID: 24295628
[TBL] [Abstract][Full Text] [Related]
18. The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine.
Singer HS; Brown J; Quaskey S; Rosenberg LA; Mellits ED; Denckla MB
Pediatrics; 1995 Jan; 95(1):74-81. PubMed ID: 7770313
[TBL] [Abstract][Full Text] [Related]
19. Psychopharmacology for the clinician: management of comorbid Tourette syndrome and attention-deficit/hyperactivity disorder: are psychostimulants an option?
Pringsheim T
J Psychiatry Neurosci; 2012 Nov; 37(6):432. PubMed ID: 23092593
[No Abstract] [Full Text] [Related]
20. Nortriptyline treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome.
Spencer T; Biederman J; Wilens T; Steingard R; Geist D
J Am Acad Child Adolesc Psychiatry; 1993 Jan; 32(1):205-10. PubMed ID: 8428873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
